AMETEK, Inc. (AME) Expected to Post Quarterly Sales of $1.18 Billion  Donna Armstrong | Aug 17th, 2018
Analysts forecast that AMETEK, Inc. (NYSE:AME) will announce sales of $1.18 billion for the current fiscal quarter, according to Zacks Investment Research . Six analysts have made estimates for AMETEK's earnings, with the highest sales estimate coming in at $1.19 billion and the lowest estimate coming in at $1.17 billion. AMETEK posted sales of $1.08 billion during the same quarter last year, which would indicate a positive year-over-year growth rate of 9.3%. The firm is expected to issue its next earnings report on Thursday, November 1st.
On average, analysts expect that AMETEK will report full year sales of $4.77 billion for the current financial year, with estimates ranging from $4.74 billion to $4.80 billion. For the next financial year, analysts expect that the firm will report sales of $5.01 billion per share, with estimates ranging from $4.96 billion to $5.04 billion. Zacks Investment Research's sales averages are an average based on a survey of sell-side research analysts that follow AMETEK. Get AMETEK alerts:
AMETEK (NYSE:AME) last issued its quarterly earnings results on Tuesday, July 31st. The technology company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.78 by $0.05. The firm had revenue of $1.21 billion for the quarter, compared to analysts' expectations of $1.19 billion. AMETEK had a net margin of 16.65% and a return on equity of 16.94%. The company's revenue for the quarter was up 13.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.65 EPS.
A number of brokerages have recently issued reports on AME. Cowen reaffirmed a "buy" rating and issued a $85.00 target price on shares of AMETEK in a report on Sunday, August 12th. Zacks Investment Research raised shares of AMETEK from a "hold" rating to a "buy" rating and set a $85.00 target price on the stock in a report on Tuesday, May 22nd. BMO Capital Markets upped their target price on shares of AMETEK from $90.00 to $92.00 and gave the company an "outperform" rating in a report on Thursday, May 3rd. Morgan Stanley upped their target price on shares of AMETEK from $76.00 to $79.00 and gave the company an "equal weight" rating in a report on Thursday, May 3rd. Finally, ValuEngine cut shares of AMETEK from a "buy" rating to a "hold" rating in a report on Monday, July 2nd. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. The stock presently has an average rating of "Buy" and an average price target of $86.08.
In related news, Director Elizebeth R. Varet sold 2,000 shares of the company's stock in a transaction dated Friday, June 8th. The shares were sold at an average price of $75.56, for a total value of $151,120.00. Following the transaction, the director now owns 113,810 shares in the company, valued at approximately $8,599,483.60. The sale was disclosed in a document filed with the SEC, which can be accessed through this link . Also, Director Elizebeth R. Varet sold 3,000 shares of the company's stock in a transaction dated Tuesday, August 7th. The shares were sold at an average price of $76.95, for a total transaction of $230,850.00. Following the completion of the transaction, the director now owns 113,810 shares in the company, valued at approximately $8,757,679.50. The disclosure for this sale can be found here . Over the last ninety days, insiders sold 12,000 shares of company stock worth $905,480. 2.00% of the stock is owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in AME. BlackRock Inc. grew its stake in AMETEK by 11.8% in the 2nd quarter. BlackRock Inc. now owns 18,178,345 shares of the technology company's stock valued at $1,311,749,000 after buying an additional 1,922,878 shares during the last quarter. Millennium Management LLC grew its stake in AMETEK by 169.1% in the 2nd quarter. Millennium Management LLC now owns 1,647,306 shares of the technology company's stock valued at $118,870,000 after buying an additional 1,035,084 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in AMETEK by 163.7% in the 1st quarter. The Manufacturers Life Insurance Company now owns 1,093,946 shares of the technology company's stock valued at $83,106,000 after buying an additional 679,049 shares during the last quarter. Renaissance Technologies LLC acquired a new position in AMETEK in the 2nd quarter valued at about $40,825,000. Finally, BNP Paribas Arbitrage SA grew its stake in AMETEK by 714.2% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 610,418 shares of the technology company's stock valued at $44,048,000 after buying an additional 535,447 shares during the last quarter. Institutional investors and hedge funds own 84.19% of the company's stock.
Shares of AME stock opened at $75.73 on Friday. The company has a current ratio of 1.71, a quick ratio of 1.19 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $17.60 billion, a PE ratio of 29.02, a PEG ratio of 2.16 and a beta of 1.26. AMETEK has a 52-week low of $61.77 and a 52-week high of $79.32.
The company also recently announced a quarterly dividend, which will be paid on Friday, September 28th. Stockholders of record on Friday, September 14th will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, September 13th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.74%. AMETEK's payout ratio is 21.46%.
About AMETEK
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. Its Electronic Instruments Group segment offers advanced instruments for the process, power and industrial, and aerospace markets; process and analytical instruments for the oil, gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage markets; and instruments for the laboratory equipment, ultraprecision manufacturing, medical, and test and measurement markets.
Get a free copy of the Zacks research report on AMETEK (AME)
For more information about research offerings from Zacks Investment Research, visit Zacks.com AMETEK AMETE